|
首字母导航: |
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
Name |
INN |
Revision |
Published |
Additional Information |
Ranexa | INN: ranolazine | Rev. 4 | 18/05/09 | |
Rapamune | INN: sirolimus | Rev. 17 | 26/11/08 | |
Rapilysin | INN: reteplase | Rev. 12 | 13/08/08 | |
Raptiva | INN: efalizumab | Rev. 8 | 29/05/09 | Press Release?(08/06/09)? Marketing Authorisation suspended - see?Press Release?(19/02/09) and the? Questions & Answers(19/02/09) |
Rasilez | INN: aliskiren | Rev. 3 | 13/05/09 | |
Rasilez HCT | INN: aliskiren hemifumarate / hydrochlorothiazide | Rev. 1 | 05/06/09 | |
Ratiograstim | INN: filgrastim | 30/09/08 | ||
Rayzon | INN: parecoxib | Rev. 4 | 01/03/05 | Marketing Authorisation withdrawn (11/08/05) Public Statement (22/10/02) |
Rebetol | INN: ribavirin | Rev. 17 | 22/12/08 | |
Rebif | INN: interferon beta-1a | Rev. 16 | 27/02/09 | |
ReFacto AF | INN: moroctocog alfa | Rev. 13 | 27/04/09 | (formerly ReFacto) |
Refludan | INN: lepirudin | Rev. 15 | 27/04/09 | |
Regranex | INN: becaplermin | Rev. 14 | 15/09/08 | |
Relistor | INN: methylnaltrexone bromide | Rev. 1 | 11/06/09 | |
Remicade | INN: infliximab | Rev. 25 | 11/03/09 | Public Statement (01/02/02) |
Removab | INN: catumaxomab | 13/05/09 | ||
Renagel | INN: sevelamer | Rev. 13 | 13/05/09 | |
Replagal | INN: agalsidase alfa | Rev. 11 | 03/11/08 | |
Retacrit | INN: epoetin zeta | Rev. 4 | 06/02/09 | |
Revasc | INN: desirudin | Rev. 8 | 03/10/07 | |
Revatio | INN: sildenafil | Rev. 13 | 12/03/09 | |
Revlimid | INN: lenalidomide | Rev. 6 | 23/04/09 | |
Reyataz | INN: atazanavir | Rev. 18 | 02/06/09 | |
Ribavirin Teva | INN: ribavirin | 14/04/09 | ||
Rilutek | INN: riluzole | Rev. 12 | 28/07/08 | |
Riprazo | INN: aliskiren | Rev. 3 | 13/05/09 | |
Rivastigmine Teva | INN: rivastigmine | 08/05/09 | ||
RoActemra | INN: tocilizumab | 19/02/09 | ||
Rotarix | Common name: human rotavirus, live attenuated | Rev. 5 | 17/11/08 | |
RotaTeq | Common name: rotavirus vaccine, live, oral | Rev. 6 | 07/11/08 |
|